Statistics for The Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitors
Total visits
| views | |
|---|---|
| The Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitors | 181 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Poster FVIIaR Canada 2000.pdf(legacy) | 300 |
| Poster FVIIaR Canada 2000.pdf | 4 |
Top country views
| views | |
|---|---|
| United States | 96 |
| Portugal | 16 |
| China | 15 |
| Russia | 15 |
| France | 9 |
| Germany | 7 |
| Netherlands | 5 |
| Canada | 4 |
| Poland | 4 |
| Turkey | 3 |
| United Kingdom | 2 |
| Chile | 1 |
| Spain | 1 |
| Israel | 1 |
| Moldova | 1 |
| Puerto Rico | 1 |